A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription-Polymerase Chain Reaction Tests For SARS-CoV-2 from a Single Laboratory in Katowice, Poland from April 2020 to July 2022.
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
02 Jan 2023
02 Jan 2023
Historique:
entrez:
13
1
2023
pubmed:
14
1
2023
medline:
17
1
2023
Statut:
epublish
Résumé
BACKGROUND This retrospective population study identified 385 191 positive real-time reverse transcription-polymerase chain reaction (RT-PCR) tests for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a single laboratory in Katowice, Poland, from April 2020 to July 2022. MATERIAL AND METHODS The material was nasopharyngeal, nasopharyngeal swab or bronchial lavage, and bronchoalveolar lavage (BAL) to confirm or exclude SARS-CoV-2 infection with the RT-PCR technique. Personal data are use according to the Provisions on the Protection of Personal Data by the Gyn-Centrum laboratory. RESULTS In 9 months of 2020, the number of SARS-CoV-2 results was 88 986; in 2021, it was 168 439, and in the first 7 months of 2022, it was 12 786. In 2020, the highest number of positive results was recorded in the third quarter (83 094 cases); 2021, in the 1st, 2nd, and 4th quarters (58 712; 37 720; and 71 753 cases, respectively), and in 2022, in the 1st quarter (127 613 cases) of the year. A positive result was observed more often in women and people aged 30-39, followed by those 40-49 years. Patients aged 10-19 years comprised the smallest population of SARS-CoV-2-positive cases. CONCLUSIONS In the Polish population studied, from April 2020 to July 2022, the detection rates of SARS-CoV-2 positivity were significantly higher for women than for men and in the 30-49 age group for both sexes. Also, the infection detection rate of 385 191 out of 1 332 659 patient samples, or 28.9%, supports that the Polish society adhered to public health recommendations for infection control during the COVID-19 pandemic.
Identifiants
pubmed: 36636983
pii: 938872
doi: 10.12659/MSM.938872
pmc: PMC9817382
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e938872Références
Front Public Health. 2020 Jul 29;8:383
pubmed: 32850602
Talanta. 2021 Mar 1;224:121726
pubmed: 33379001
Bioengineering (Basel). 2021 Apr 17;8(4):
pubmed: 33920513
Genomics. 2021 Jan;113(1 Pt 2):1221-1232
pubmed: 33007398
J Med Virol. 2020 Jun;92(6):538-539
pubmed: 32096564
J Hepatol. 2021 Jan;74(1):168-184
pubmed: 33038433
Nat Rev Immunol. 2021 Aug;21(8):475-484
pubmed: 34211186
Br J Anaesth. 2020 Sep;125(3):e330-e332
pubmed: 32534738
Br J Hosp Med (Lond). 2020 Aug 2;81(8):1-10
pubmed: 32845750
Vaccines (Basel). 2021 Nov 09;9(11):
pubmed: 34835230
Arch Virol. 2017 Jun;162(6):1617-1623
pubmed: 28220326
Infect Genet Evol. 2020 Jul;81:104260
pubmed: 32092483
J Med Virol. 2020 Nov;92(11):2257-2259
pubmed: 32470174
Pathogens. 2022 Jul 08;11(7):
pubmed: 35890025
Lancet. 2021 Jul 31;398(10298):385-387
pubmed: 34274038
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551
pubmed: 32112072
ERJ Open Res. 2020 Aug 17;6(3):
pubmed: 32832527
Expert Rev Mol Diagn. 2020 May;20(5):453-454
pubmed: 32297805
Int J Mol Sci. 2016 Nov 23;17(11):
pubmed: 27886052
Euro Surveill. 2020 Mar;25(11):
pubmed: 32186277
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
J Neuroimmune Pharmacol. 2021 Mar;16(1):38-47
pubmed: 33405098
Nat Med. 2021 Nov;27(11):2025-2031
pubmed: 34526698
Sci China Life Sci. 2020 May;63(5):706-711
pubmed: 32146694
PLoS One. 2020 Dec 10;15(12):e0242958
pubmed: 33301459
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):407-412
pubmed: 32335367
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156330
J Pharm Anal. 2020 Apr;10(2):97-101
pubmed: 32292623
Int J Environ Res Public Health. 2020 Sep 09;17(18):
pubmed: 32916973
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
J Korean Med Sci. 2020 Mar 16;35(10):e112
pubmed: 32174069
Expert Rev Mol Diagn. 2020 Sep;20(9):985-993
pubmed: 32845192
FEBS J. 2020 Sep;287(17):3633-3650
pubmed: 32446285